{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:57:11Z","timestamp":1794952631301,"version":"4.9.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82371422"],"award-info":[{"award-number":["82371422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2703101"],"award-info":[{"award-number":["2022YFC2703101"]}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence Clinical Research Fund, West China Hospital, Sichuan University","award":["2023HXFH032"],"award-info":[{"award-number":["2023HXFH032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03677-z","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:41:24Z","timestamp":1770205284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["From pathogenesis to therapy: the emerging role of regulatory T cells in amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ming","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"3677_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13024-025-00876-3","volume":"20","author":"T Burg","year":"2025","unstructured":"Burg T, Van Den Bosch L. Glycerophospholipids in ALS: insights into disease mechanisms and clinical implication. Mol Neurodegener. 2025;20:85.","journal-title":"Mol Neurodegener"},{"key":"3677_CR2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jgg.2025.05.008","volume":"52","author":"L Yuan","year":"2025","unstructured":"Yuan L, Yang Y, Guo Y, Deng H. Genetic architecture of amyotrophic lateral sclerosis: a comprehensive review. J Genet Genomics. 2025;52:1155\u201376.","journal-title":"J Genet Genomics"},{"key":"3677_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S1474-4422(24)00517-9","volume":"24","author":"TG Moens","year":"2025","unstructured":"Moens TG, Da Cruz S, Neumann M, Shelkovnikova TA, Shneider NA, Van Den Bosch L. Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications. Lancet Neurol. 2025;24:166\u201378.","journal-title":"Lancet Neurol"},{"key":"3677_CR4","doi-asserted-by":"crossref","unstructured":"Wen X, Lan T, Su W, Cao B, Wang Y, Chen Y. Latest progress and challenges in drug development for degenerative motor neuron diseases. Neural Regen Res. 2026;21:1849\u201363.","DOI":"10.4103\/NRR.NRR-D-24-01266"},{"key":"3677_CR5","doi-asserted-by":"publisher","first-page":"105863","DOI":"10.1016\/j.ebiom.2025.105863","volume":"118","author":"MG Fehlings","year":"2025","unstructured":"Fehlings MG, Pedro KM, Alvi MA, Moghaddamjou A, Harrop JS, Stanford R, Ball J, Aarabi B, Arnold PM, Guest JD, et al. The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique. EBioMedicine. 2025;118:105863.","journal-title":"EBioMedicine"},{"key":"3677_CR6","doi-asserted-by":"crossref","unstructured":"Yuan J, Liao YS, Zhang TC, Liu S, Ruan MM, Yang TT, et al. Disrupted lipid metabolism aggravates ischemic brain injury: targeting FDFT1 for stroke therapy. Mol Neurobiol. 2025;62:14227\u201344.","DOI":"10.1007\/s12035-025-05217-5"},{"key":"3677_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s40263-025-01204-5","volume":"39","author":"A McGuigan","year":"2025","unstructured":"McGuigan A, Blair HA. Tofersen: a review in amyotrophic lateral sclerosis associated with SOD1 mutations. CNS Drugs. 2025;39:903\u201312.","journal-title":"CNS Drugs"},{"key":"3677_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197\u2013206.","journal-title":"Nature"},{"key":"3677_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12916-024-03314-1","volume":"22","author":"QQ Duan","year":"2024","unstructured":"Duan QQ, Wang H, Su WM, Gu XJ, Shen XF, Jiang Z, Ren YL, Cao B, Li GB, Wang Y, Chen YP. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and Pharmacological verification in vitro. BMC Med. 2024;22:96.","journal-title":"BMC Med"},{"key":"3677_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-019-02009-9","volume":"137","author":"R Brambilla","year":"2019","unstructured":"Brambilla R. Neuroinflammation, the thread connecting neurological disease. Acta Neuropathol. 2019;137:689\u201391.","journal-title":"Acta Neuropathol"},{"key":"3677_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-020-00375-7","volume":"15","author":"J Machhi","year":"2020","unstructured":"Machhi J, Kevadiya BD, Muhammad IK, Herskovitz J, Olson KE, Mosley RL, Gendelman HE. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol Neurodegener. 2020;15:32.","journal-title":"Mol Neurodegener"},{"key":"3677_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 2019;18:211\u201320.","journal-title":"Lancet Neurol"},{"key":"3677_CR13","doi-asserted-by":"publisher","first-page":"EVIDoa2400249","DOI":"10.1056\/EVIDoa2400249","volume":"4","author":"NA Shneider","year":"2025","unstructured":"Shneider NA, Nesta AV, Rifai OM, Yasek J, Elyaman W, Aziz-Zaman S, Lyu MA, Levy SHS, Hoover BN, Vlad G, et al. Clinical safety and preliminary efficacy of regulatory T cells for ALS. NEJM Evid. 2025;4:EVIDoa2400249.","journal-title":"NEJM Evid"},{"key":"3677_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/cmi.2015.10","volume":"12","author":"Z Li","year":"2015","unstructured":"Li Z, Li D, Tsun A, Li B. FOXP3\u2009+\u2009regulatory T cells and their functional regulation. Cell Mol Immunol. 2015;12:558\u201365.","journal-title":"Cell Mol Immunol"},{"key":"3677_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","volume":"38","author":"PA Savage","year":"2020","unstructured":"Savage PA, Klawon DEJ, Miller CH. Regulatory T cell development. Annu Rev Immunol. 2020;38:421\u201353.","journal-title":"Annu Rev Immunol"},{"key":"3677_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12967-024-05104-y","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang C, Jiang A, Lin A, Liu Z, Cheng X, Wang W, Cheng Q, Zhang J, Wei T, Luo P. Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review. J Transl Med. 2024;22:293.","journal-title":"J Transl Med"},{"key":"3677_CR17","doi-asserted-by":"publisher","first-page":"e88318","DOI":"10.1371\/journal.pone.0088318","volume":"9","author":"L Schreiber","year":"2014","unstructured":"Schreiber L, Pietzsch B, Floess S, Farah C, J\u00e4nsch L, Schmitz I, Huehn J. The Treg-specific demethylated region stabilizes Foxp3 expression independently of NF-\u03baB signaling. PLoS ONE. 2014;9:e88318.","journal-title":"PLoS ONE"},{"key":"3677_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fimmu.2017.00219","volume":"8","author":"EK Alvarez Salazar","year":"2017","unstructured":"Alvarez Salazar EK, Cort\u00e9s-Hern\u00e1ndez A, Alem\u00e1n-Muench GR, Alber\u00fa J, Rodr\u00edguez-Aguilera JR, Recillas-Targa F, Chagoya de S\u00e1nchez V, Cuevas E, Mancilla-Urrea E, P\u00e9rez Garc\u00eda M, et al. Methylation of FOXP3 TSDR underlies the impaired suppressive function of Tregs from Long-term Belatacept-Treated kidney transplant patients. Front Immunol. 2017;8:219.","journal-title":"Front Immunol"},{"key":"3677_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaut.2017.07.002","volume":"83","author":"M Iizuka-Koga","year":"2017","unstructured":"Iizuka-Koga M, Nakatsukasa H, Ito M, Akanuma T, Lu Q, Yoshimura A. Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications. J Autoimmun. 2017;83:113\u201321.","journal-title":"J Autoimmun"},{"key":"3677_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2302\/kjm.2019-0003-OA","volume":"69","author":"R Sakai","year":"2020","unstructured":"Sakai R, Komai K, Iizuka-Koga M, Yoshimura A, Ito M. Regulatory T cells: pathophysiological roles and clinical applications. Keio J Med. 2020;69:1\u201315.","journal-title":"Keio J Med"},{"key":"3677_CR21","doi-asserted-by":"publisher","first-page":"117664","DOI":"10.1016\/j.biopha.2024.117664","volume":"181","author":"K Zuo","year":"2024","unstructured":"Zuo K, Liu N, Zhou P, Zheng M, Wang L, Tang T, Yang Z, Chen L, Zhu X. Human serum albumin promotes interactions between HSA-IL-2 fusion protein and CD122 for enhancing immunotherapy. Biomed Pharmacother. 2024;181:117664.","journal-title":"Biomed Pharmacother"},{"key":"3677_CR22","doi-asserted-by":"publisher","first-page":"112996","DOI":"10.1016\/j.celrep.2023.112996","volume":"42","author":"H Sun","year":"2023","unstructured":"Sun H, Lee HS, Kim SH, Fernandes de Lima M, Gingras AR, Du Q, McLaughlin W, Ablack J, Lopez-Ramirez MA, Lagarrigue F, et al. IL-2 can signal via chemokine receptors to promote regulatory T cells\u2019 suppressive function. Cell Rep. 2023;42:112996.","journal-title":"Cell Rep"},{"key":"3677_CR23","doi-asserted-by":"publisher","first-page":"2405133","DOI":"10.1002\/adfm.202405133","volume":"34","author":"L Yu","year":"2024","unstructured":"Yu L, Fu Y, Miao R, Cao J, Zhang F, Liu L, Mei L, Ou M. Regulatory T cells and their derived cell pharmaceuticals as emerging therapeutics against autoimmune diseases. Adv Funct Mater. 2024;34:2405133.","journal-title":"Adv Funct Mater"},{"key":"3677_CR24","doi-asserted-by":"publisher","first-page":"1444533","DOI":"10.3389\/fimmu.2024.1444533","volume":"15","author":"Y Yue","year":"2024","unstructured":"Yue Y, Ren Y, Lu C, Li P, Zhang G. Epigenetic regulation of human FOXP3\u2009+\u2009Tregs: from homeostasis maintenance to pathogen defense. Front Immunol. 2024;15:1444533.","journal-title":"Front Immunol"},{"key":"3677_CR25","doi-asserted-by":"publisher","first-page":"e23786","DOI":"10.1096\/fj.202400839R","volume":"38","author":"V Kumar","year":"2024","unstructured":"Kumar V, Narisawa M, Cheng XW. Overview of multifunctional Tregs in cardiovascular disease: from insights into cellular functions to clinical implications. Faseb J. 2024;38:e23786.","journal-title":"Faseb J"},{"key":"3677_CR26","doi-asserted-by":"publisher","first-page":"1581093","DOI":"10.3389\/fimmu.2025.1581093","volume":"16","author":"L Zheng","year":"2025","unstructured":"Zheng L, Wu D, Xie H, Zhao H. Revisiting Tregs in cancer and beyond: immunological control and therapeutic potential. Front Immunol. 2025;16:1581093.","journal-title":"Front Immunol"},{"key":"3677_CR27","doi-asserted-by":"publisher","first-page":"1075813","DOI":"10.3389\/fimmu.2022.1075813","volume":"13","author":"F Ghobadinezhad","year":"2022","unstructured":"Ghobadinezhad F, Ebrahimi N, Mozaffari F, Moradi N, Beiranvand S, Pournazari M, Rezaei-Tazangi F, Khorram R, Afshinpour M, Robino RA, et al. The emerging role of regulatory cell-based therapy in autoimmune disease. Front Immunol. 2022;13:1075813.","journal-title":"Front Immunol"},{"key":"3677_CR28","doi-asserted-by":"crossref","unstructured":"Dong D, Sindhava VJ, Ganesan A, Naradikian MS, Stephen TL, Frisch A, et al. Normal Treg homeostasis and suppressive function require both FOXP1 and FOXP4. JCI Insight. 2025;10:e195981.","DOI":"10.1172\/jci.insight.195981"},{"key":"3677_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.it.2009.09.003","volume":"31","author":"SH Appel","year":"2010","unstructured":"Appel SH, Beers DR, Henkel JS. T cell-microglial dialogue in parkinson\u2019s disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol. 2010;31:7\u201317.","journal-title":"Trends Immunol"},{"key":"3677_CR30","doi-asserted-by":"publisher","first-page":"e89530","DOI":"10.1172\/jci.insight.89530","volume":"2","author":"DR Beers","year":"2017","unstructured":"Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D, Thonhoff JR, Alsuliman AS, Shpall EJ, Rezvani K, Appel SH. ALS patients\u2019 regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2017;2:e89530.","journal-title":"JCI Insight"},{"key":"3677_CR31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T. Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells. 2023;12:1012.","journal-title":"Cells"},{"key":"3677_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fncel.2014.00117","volume":"8","author":"D Brites","year":"2014","unstructured":"Brites D, Vaz AR. Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front Cell Neurosci. 2014;8:117.","journal-title":"Front Cell Neurosci"},{"key":"3677_CR33","doi-asserted-by":"publisher","first-page":"1223096","DOI":"10.3389\/fimmu.2023.1223096","volume":"14","author":"M Calafatti","year":"2023","unstructured":"Calafatti M, Cocozza G, Limatola C, Garofalo S. Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis. Front Immunol. 2023;14:1223096.","journal-title":"Front Immunol"},{"key":"3677_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-022-02512-z","volume":"19","author":"SY Park","year":"2022","unstructured":"Park SY, Yang H, Ye M, Liu X, Shim I, Chang YT, Bae H. Neuroprotective effects of ex vivo-expanded regulatory T cells on trimethyltin-induced neurodegeneration in mice. J Neuroinflammation. 2022;19:143.","journal-title":"J Neuroinflammation"},{"key":"3677_CR35","doi-asserted-by":"crossref","unstructured":"Kopitar-Jerala N. Innate immune response in brain, NF-Kappa B signaling and cystatins. Front Mol Neurosci. 2015;8:73.","DOI":"10.3389\/fnmol.2015.00073"},{"key":"3677_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","volume":"565","author":"M Ito","year":"2019","unstructured":"Ito M, Komai K, Mise-Omata S, Iizuka-Koga M, Noguchi Y, Kondo T, Sakai R, Matsuo K, Nakayama T, Yoshie O, et al. Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery. Nature. 2019;565:246\u201350.","journal-title":"Nature"},{"key":"3677_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s11481-019-09888-5","volume":"15","author":"Y Huang","year":"2020","unstructured":"Huang Y, Liu Z, Cao BB, Qiu YH, Peng YP. Treg cells attenuate neuroinflammation and protect neurons in a mouse model of parkinson\u2019s disease. J Neuroimmune Pharmacol. 2020;15:224\u201337.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3677_CR38","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1038\/s41598-020-62756-8","volume":"10","author":"M Jin","year":"2020","unstructured":"Jin M, G\u00fcnther R, Akg\u00fcn K, Hermann A, Ziemssen T. Peripheral Proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep. 2020;10:5941.","journal-title":"Sci Rep"},{"key":"3677_CR39","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.3390\/cimb46080465","volume":"46","author":"M Sacharczuk","year":"2024","unstructured":"Sacharczuk M, Mickael ME, Kubick N, Kami\u0144ska A, Horba\u0144czuk JO, Atanasov AG, Religa P, \u0141awi\u0144ski M. The current landscape of hypotheses describing the contribution of CD4\u2009+\u2009Heterogeneous populations to ALS. Curr Issues Mol Biol. 2024;46:7846\u201361.","journal-title":"Curr Issues Mol Biol"},{"key":"3677_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/21678421.2020.1752246","volume":"21","author":"I Giovannelli","year":"2020","unstructured":"Giovannelli I, Heath P, Shaw PJ, Kirby J. The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:435\u201344.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"3677_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.nbd.2012.07.008","volume":"48","author":"W Zhao","year":"2012","unstructured":"Zhao W, Beers DR, Liao B, Henkel JS, Appel SH. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol Dis. 2012;48:418\u201328.","journal-title":"Neurobiol Dis"},{"key":"3677_CR42","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/brain\/awr074","volume":"134","author":"DR Beers","year":"2011","unstructured":"Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, Liao B, Appel SH. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain. 2011;134:1293\u2013314.","journal-title":"Brain"},{"key":"3677_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamaneurol.2018.0035","volume":"75","author":"RK Sheean","year":"2018","unstructured":"Sheean RK, McKay FC, Cretney E, Bye CR, Perera ND, Tomas D, Weston RA, Scheller KJ, Djouma E, Menon P, et al. Association of regulatory T-Cell expansion with progression of amyotrophic lateral sclerosis: A study of humans and a Transgenic mouse model. JAMA Neurol. 2018;75:681\u20139.","journal-title":"JAMA Neurol"},{"key":"3677_CR44","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","volume":"13","author":"S Yazdani","year":"2022","unstructured":"Yazdani S, Seitz C, Cui C, Lovik A, Pan L, Piehl F, Pawitan Y, Kl\u00e4ppe U, Press R, Samuelsson K, et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat Commun. 2022;13:6733.","journal-title":"Nat Commun"},{"key":"3677_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12974-024-03327-w","volume":"21","author":"T Itou","year":"2024","unstructured":"Itou T, Fujita K, Okuzono Y, Warude D, Miyakawa S, Mihara Y, Matsui N, Morino H, Kikukawa Y, Izumi Y. Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study. J Neuroinflammation. 2024;21:331.","journal-title":"J Neuroinflammation"},{"key":"3677_CR46","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1212\/NXI.0000000000000465","volume":"5","author":"JR Thonhoff","year":"2018","unstructured":"Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, Cudkowicz ME, Appel SH. Expanded autologous regulatory T-lymphocyte infusions in ALS. Neurol Neuroimmunol Neuroinflammation. 2018;5:e465.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"3677_CR47","doi-asserted-by":"crossref","unstructured":"Thonhoff JR, Berry JD, Macklin EA, Beers DR, Mendoza PA, Zhao W, et al. Combined regulatory T-Lymphocyte and IL-2 treatment is Safe, Tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022;9:e200019.","DOI":"10.1212\/NXI.0000000000200019"},{"key":"3677_CR48","doi-asserted-by":"crossref","unstructured":"Thonhoff JR, Beers DR, Zhao W, Faridar A, Thome A, Wen S, et al. A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis. Front Neurol. 2024;15:1415106.","DOI":"10.3389\/fneur.2024.1415106"},{"key":"3677_CR49","doi-asserted-by":"publisher","first-page":"102844","DOI":"10.1016\/j.ebiom.2020.102844","volume":"59","author":"W Camu","year":"2020","unstructured":"Camu W, Mickunas M, Veyrune JL, Payan C, Garlanda C, Locati M, Juntas-Morales R, Pageot N, Malaspina A, Andreasson U, et al. Repeated 5-day cycles of low dose Aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844.","journal-title":"EBioMedicine"},{"key":"3677_CR50","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0140-6736(25)00262-4","volume":"405","author":"G Bensimon","year":"2025","unstructured":"Bensimon G, Leigh PN, Tree T, Malaspina A, Payan CA, Pham HP, Klaassen P, Shaw PJ, Al Khleifat A, Amador MDM, et al. Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial. Lancet. 2025;405:1837\u201350.","journal-title":"Lancet"},{"key":"3677_CR51","doi-asserted-by":"publisher","first-page":"e11119","DOI":"10.1097\/MD.0000000000011119","volume":"97","author":"J Mandrioli","year":"2018","unstructured":"Mandrioli J, D\u2019Amico R, Zucchi E, Gessani A, Fini N, Fasano A, Caponnetto C, Chi\u00f2 A, Dalla Bella E, Lunetta C, et al. Rapamycin treatment for amyotrophic lateral sclerosis: protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial). Med (Baltim). 2018;97:e11119.","journal-title":"Med (Baltim)"},{"key":"3677_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/mus.26385","volume":"59","author":"S Paganoni","year":"2019","unstructured":"Paganoni S, Alshikho MJ, Luppino S, Chan J, Pothier L, Schoenfeld D, Andres PL, Babu S, Z\u00fcrcher NR, Loggia ML, et al. A pilot trial of RNS60 in amyotrophic lateral sclerosis. Muscle Nerve. 2019;59:303\u20138.","journal-title":"Muscle Nerve"},{"key":"3677_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ene.15573","volume":"30","author":"E Beghi","year":"2023","unstructured":"Beghi E, Pupillo E, Bianchi E, Bonetto V, Luotti S, Pasetto L, Bendotti C, Tortarolo M, Sironi F, Camporeale L, et al. Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial. Eur J Neurol. 2023;30:69\u201386.","journal-title":"Eur J Neurol"},{"key":"3677_CR54","doi-asserted-by":"crossref","unstructured":"Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E, D'Amico R, et al. FETR-ALS study protocol: a randomized clinical trial of fecal microbiota transplantation in amyotrophic lateral sclerosis. Front Neurol. 2019;10:1021.","DOI":"10.3389\/fneur.2019.01021"},{"key":"3677_CR55","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/acn3.51446","volume":"8","author":"S Vucic","year":"2021","unstructured":"Vucic S, Henderson RD, Mathers S, Needham M, Schultz D, Kiernan MC. Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study. Ann Clin Transl Neurol. 2021;8:1991\u20139.","journal-title":"Ann Clin Transl Neurol"},{"key":"3677_CR56","doi-asserted-by":"publisher","first-page":"1166135","DOI":"10.3389\/fimmu.2023.1166135","volume":"14","author":"JA Bluestone","year":"2023","unstructured":"Bluestone JA, McKenzie BS, Beilke J, Ramsdell F. Opportunities for Treg cell therapy for the treatment of human disease. Front Immunol. 2023;14:1166135.","journal-title":"Front Immunol"},{"key":"3677_CR57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ana.26375","volume":"92","author":"DR Beers","year":"2022","unstructured":"Beers DR, Thonhoff JR, Faridar A, Thome AD, Zhao W, Wen S, Appel SH. Tregs attenuate peripheral oxidative stress and acute phase proteins in ALS. Ann Neurol. 2022;92:195\u2013200.","journal-title":"Ann Neurol"},{"key":"3677_CR58","doi-asserted-by":"publisher","first-page":"eaat1482","DOI":"10.1126\/sciimmunol.aat1482","volume":"3","author":"AK Abbas","year":"2018","unstructured":"Abbas AK, Trotta E, Simeonov R, Marson D, Bluestone A. Revisiting IL-2: biology and therapeutic prospects. Sci Immunol. 2018;3:eaat1482.","journal-title":"Sci Immunol"},{"key":"3677_CR59","doi-asserted-by":"publisher","first-page":"ra179143","DOI":"10.1126\/scitranslmed.3005265","volume":"5","author":"K-i Matsuoka","year":"2013","unstructured":"Matsuoka K-i, Koreth J, Kim HT, Bascug G, McDonough S, Kawano Y, Murase K, Cutler C, Ho VT, Alyea EP, et al. Low-Dose Interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic Graft-Versus-Host disease. Sci Transl Med. 2013;5:ra179143\u2013179143.","journal-title":"Sci Transl Med"},{"key":"3677_CR60","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cyto.2014.05.021","volume":"69","author":"G Dupont","year":"2014","unstructured":"Dupont G, Demaret J, Venet F, Malergue F, Malcus C, Poitevin-Later F, Morel J, Monneret G. Comparative dose-responses of Recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4\u2009+\u2009FOXP3- cells versus regulatory T cells: a whole blood perspective. Cytokine. 2014;69:146\u20139.","journal-title":"Cytokine"},{"key":"3677_CR61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","volume":"20","author":"C Raffin","year":"2020","unstructured":"Raffin C, Vo LT, Bluestone JA. T(reg) cell-based therapies: challenges and perspectives. Nat Rev Immunol. 2020;20:158\u201372.","journal-title":"Nat Rev Immunol"},{"key":"3677_CR62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.15147","volume":"1536","author":"H Alarcan","year":"2024","unstructured":"Alarcan H, Bruno C, Emond P, Raoul C, Vourc\u2019h P, Corcia P, Camu W, Veyrune JL, Garlanda C, Locati M, et al. Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosis. Ann N Y Acad Sci. 2024;1536:82\u201391.","journal-title":"Ann N Y Acad Sci"},{"key":"3677_CR63","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.transproceed.2019.04.067","volume":"51","author":"J Zhang","year":"2019","unstructured":"Zhang J, Jin H, Xu Y, Shan J. Rapamycin modulate Treg\/Th17 balance via regulating metabolic pathways: A study in mice. Transpl Proc. 2019;51:2136\u201340.","journal-title":"Transpl Proc"},{"key":"3677_CR64","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng H, Yang K, Cloer C, Neale G, Vogel P, Chi H. mTORC1 couples immune signals and metabolic programming to Establish T(reg)-cell function. Nature. 2013;499:485\u201390.","journal-title":"Nature"},{"key":"3677_CR65","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jcyt.2016.06.012","volume":"18","author":"A Alsuliman","year":"2016","unstructured":"Alsuliman A, Appel SH, Beers DR, Basar R, Shaim H, Kaur I, Zulovich J, Yvon E, Muftuoglu M, Imahashi N, et al. A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. Cytotherapy. 2016;18:1312\u201324.","journal-title":"Cytotherapy"},{"key":"3677_CR66","doi-asserted-by":"publisher","first-page":"29529","DOI":"10.1074\/jbc.M111.338012","volume":"287","author":"S Khasnavis","year":"2012","unstructured":"Khasnavis S, Jana A, Roy A, Mazumder M, Bhushan B, Wood T, Ghosh S, Watson R, Pahan K. Suppression of nuclear factor-\u03baB activation and inflammation in microglia by physically modified saline. J Biol Chem. 2012;287:29529\u201342.","journal-title":"J Biol Chem"},{"key":"3677_CR67","doi-asserted-by":"publisher","first-page":"e0295504","DOI":"10.1371\/journal.pone.0295504","volume":"19","author":"GP Baena-Caldas","year":"2024","unstructured":"Baena-Caldas GP, Li J, Pedraza L, Ghosh S, Kalmes A, Barone FC, Moreno H, Hern\u00e1ndez AI. Neuroprotective effect of the RNS60 in a mouse model of transient focal cerebral ischemia. PLoS ONE. 2024;19:e0295504.","journal-title":"PLoS ONE"},{"key":"3677_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12974-018-1101-0","volume":"15","author":"A Vallarola","year":"2018","unstructured":"Vallarola A, Sironi F, Tortarolo M, Gatto N, De Gioia R, Pasetto L, De Paola M, Mariani A, Ghosh S, Watson R, et al. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue. J Neuroinflammation. 2018;15:65.","journal-title":"J Neuroinflammation"},{"key":"3677_CR69","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s11064-017-2214-z","volume":"42","author":"S Mondal","year":"2017","unstructured":"Mondal S, Rangasamy SB, Ghosh S, Watson RL, Pahan K. Nebulization of RNS60, a Physically-Modified Saline, attenuates the adoptive transfer of experimental allergic encephalomyelitis in mice: implications for multiple sclerosis therapy. Neurochem Res. 2017;42:1555\u201370.","journal-title":"Neurochem Res"},{"key":"3677_CR70","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.bbi.2024.08.044","volume":"122","author":"E Pupillo","year":"2024","unstructured":"Pupillo E, Bianchi E, Bonetto V, Pasetto L, Bendotti C, Paganoni S, Mandrioli J, Mazzini L. Long-term survival of participants in a phase II randomized trial of RNS60 in amyotrophic lateral sclerosis. Brain Behav Immun. 2024;122:456\u201362.","journal-title":"Brain Behav Immun"},{"key":"3677_CR71","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/med.21567","volume":"39","author":"NEB Saidu","year":"2019","unstructured":"Saidu NEB, Kavian N, Leroy K, Jacob C, Nicco C, Batteux F, Alexandre J. Dimethyl fumarate, a two-edged drug: current status and future directions. Med Res Rev. 2019;39:1923\u201352.","journal-title":"Med Res Rev"},{"key":"3677_CR72","doi-asserted-by":"publisher","first-page":"1375340","DOI":"10.3389\/fimmu.2024.1375340","volume":"15","author":"Y Cen","year":"2024","unstructured":"Cen Y, Li F, Li Y, Zhang K, Riaz F, Zhao K, Wei P, Pan F. Dimethyl fumarate alleviates allergic asthma by strengthening the Nrf2 signaling pathway in regulatory T cells. Front Immunol. 2024;15:1375340.","journal-title":"Front Immunol"},{"key":"3677_CR73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/bjd.19229","volume":"184","author":"J Sulaimani","year":"2021","unstructured":"Sulaimani J, Cluxton D, Clowry J, Petrasca A, Molloy OE, Moran B, Sweeney CM, Malara A, McNicholas N, McGuigan C, et al. Dimethyl fumarate modulates the Treg\u2013Th17 cell axis in patients with psoriasis*. Br J Dermatol. 2021;184:495\u2013503.","journal-title":"Br J Dermatol"},{"key":"3677_CR74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s13668-025-00663-y","volume":"14","author":"Z Savran","year":"2025","unstructured":"Savran Z, Baltaci SB, Aladag T, Mogulkoc R, Baltaci AK. Vitamin D and neurodegenerative diseases such as multiple sclerosis (MS), parkinson\u2019s disease (PD), alzheimer\u2019s disease (AD), and amyotrophic lateral sclerosis (ALS): A review of current literature. Curr Nutr Rep. 2025;14:77.","journal-title":"Curr Nutr Rep"},{"key":"3677_CR75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/0118715273330972241009092828","volume":"24","author":"A Al Noman","year":"2025","unstructured":"Al Noman A, Afrosa H, Lihu IK, Sarkar O, Nabin NR, Datta M, Pathak R, Sharma H. Vitamin D and neurological health: unraveling risk Factors, disease Progression, and treatment potential. CNS Neurol Disord Drug Targets. 2025;24:245\u201356.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3677_CR76","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.4049\/jimmunol.1101211","volume":"188","author":"SW Kang","year":"2012","unstructured":"Kang SW, Kim SH, Lee N, Lee WW, Hwang KA, Shin MS, Lee SH, Kim WU, Kang I. 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. J Immunol. 2012;188:5276\u201382.","journal-title":"J Immunol"},{"key":"3677_CR77","doi-asserted-by":"publisher","first-page":"25154","DOI":"10.1038\/s41598-025-10821-5","volume":"15","author":"D Li","year":"2025","unstructured":"Li D, Ma X, Zhang W, Zhong P, Li M, Liu S. Impact of vitamin D3 supplementation on motor functionality and the immune response in parkinson\u2019s disease patients with vitamin D deficiency. Sci Rep. 2025;15:25154.","journal-title":"Sci Rep"},{"key":"3677_CR78","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.neurobiolaging.2013.11.005","volume":"35","author":"W Camu","year":"2014","unstructured":"Camu W, Tremblier B, Plassot C, Alphandery S, Salsac C, Pageot N, Juntas-Morales R, Scamps F, Daures JP, Raoul C. Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35:1198\u2013205.","journal-title":"Neurobiol Aging"},{"key":"3677_CR79","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.jocn.2013.01.011","volume":"20","author":"C Karam","year":"2013","unstructured":"Karam C, Barrett MJ, Imperato T, MacGowan DJ, Scelsa S. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis. J Clin Neurosci. 2013;20:1550\u20133.","journal-title":"J Clin Neurosci"},{"key":"3677_CR80","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/cns.12423","volume":"21","author":"H Blasco","year":"2015","unstructured":"Blasco H, Madji Hounoum B, Dufour-Rainfray D, Patin F, Maillot F, Beltran S, Gordon PH, Andres CR, Corcia P. Vitamin D is not a protective factor in ALS. CNS Neurosci Ther. 2015;21:651\u20136.","journal-title":"CNS Neurosci Ther"},{"key":"3677_CR81","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jns.2016.05.007","volume":"367","author":"J Yang","year":"2016","unstructured":"Yang J, Park J-S, Oh K-W, Oh S-i, Park H-M, Kim SH. Vitamin D levels are not predictors of survival in a clinic population of patients with ALS. J Neurol Sci. 2016;367:83\u20138.","journal-title":"J Neurol Sci"},{"key":"3677_CR82","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41430-019-0448-3","volume":"74","author":"F Trojsi","year":"2020","unstructured":"Trojsi F, Siciliano M, Passaniti C, Bisecco A, Russo A, Lavorgna L, Esposito S, Ricciardi D, Monsurr\u00f2 MR, Tedeschi G, Santangelo G. Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS). Eur J Clin Nutr. 2020;74:167\u201375.","journal-title":"Eur J Clin Nutr"},{"key":"3677_CR83","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12017-025-08870-0","volume":"27","author":"VK Sharma","year":"2025","unstructured":"Sharma VK. Dysbiosis and neurodegeneration in ALS: unraveling the Gut-Brain axis. Neuromolecular Med. 2025;27:50.","journal-title":"Neuromolecular Med"},{"key":"3677_CR84","doi-asserted-by":"publisher","first-page":"2353396","DOI":"10.1080\/19490976.2024.2353396","volume":"16","author":"J Yan","year":"2024","unstructured":"Yan J, Chen H, Zhang Y, Peng L, Wang Z, Lan X, Yu S, Yang Y. Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis. Gut Microbes. 2024;16:2353396.","journal-title":"Gut Microbes"},{"key":"3677_CR85","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2022.08.003","volume":"150","author":"M Doglio","year":"2022","unstructured":"Doglio M, Alexander T, Del Papa N, Snowden JA, Greco R. New insights in systemic lupus erythematosus: from regulatory T cells to CAR-T-cell strategies. J Allergy Clin Immunol. 2022;150:1289\u2013301.","journal-title":"J Allergy Clin Immunol"},{"key":"3677_CR86","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jgg.2022.05.005","volume":"49","author":"G Qu","year":"2022","unstructured":"Qu G, Chen J, Li Y, Yuan Y, Liang R, Li B. Current status and perspectives of regulatory T cell-based therapy. J Genet Genomics. 2022;49:599\u2013611.","journal-title":"J Genet Genomics"},{"key":"3677_CR87","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","volume":"127","author":"CG Brunstein","year":"2016","unstructured":"Brunstein CG, Miller JS, McKenna DH, Hippen KL, DeFor TE, Sumstad D, Curtsinger J, Verneris MR, MacMillan ML, Levine BL, et al. Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. Blood. 2016;127:1044\u201351.","journal-title":"Blood"},{"key":"3677_CR88","doi-asserted-by":"publisher","first-page":"1081644","DOI":"10.3389\/fcell.2022.1081644","volume":"10","author":"L Amini","year":"2022","unstructured":"Amini L, Kaeda J, Fritsche E, Roemhild A, Kaiser D, Reinke P. Clinical adoptive regulatory T cell therapy: state of the art, challenges, and prospective. Front Cell Dev Biol. 2022;10:1081644.","journal-title":"Front Cell Dev Biol"},{"key":"3677_CR89","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3389\/fimmu.2017.01117","volume":"8","author":"PR Adair","year":"2017","unstructured":"Adair PR, Kim YC, Zhang A-H, Yoon J, Scott DW. Human Tregs made antigen specific by gene modification: the power to treat autoimmunity and antidrug antibodies with precision. Front Immunol. 2017;8:2017.","journal-title":"Front Immunol"},{"key":"3677_CR90","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3389\/fmolb.2023.1267762","volume":"10","author":"CJ Requejo Cier","year":"2023","unstructured":"Requejo Cier CJ, Valentini N, Lamarche C. Unlocking the potential of tregs: innovations in CAR technology. Front Mol Biosci. 2023;10:2023.","journal-title":"Front Mol Biosci"},{"key":"3677_CR91","doi-asserted-by":"crossref","unstructured":"Eggenhuizen PJ, Ng BH, Ooi JD. Treg enhancing therapies to treat autoimmune diseases. Int J Mol Sci. 2020;21:7015.","DOI":"10.3390\/ijms21197015"},{"key":"3677_CR92","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40364-017-0102-y","volume":"5","author":"C Zhang","year":"2017","unstructured":"Zhang C, Liu J, Zhong JF, Zhang X. Engineering CAR-T cells. Biomark Res. 2017;5:22.","journal-title":"Biomark Res"},{"key":"3677_CR93","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nrclinonc.2016.36","volume":"13","author":"HJ Jackson","year":"2016","unstructured":"Jackson HJ, Rafiq S, Brentjens RJ. Driving CAR T-cells forward. Nat Rev Clin Oncol. 2016;13:370\u201383.","journal-title":"Nat Rev Clin Oncol"},{"key":"3677_CR94","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcyt.2023.11.007","volume":"26","author":"DJ Graber","year":"2024","unstructured":"Graber DJ, Cook WJ, Sentman M-L, Murad-Mabaera JM, Sentman CL. Human CD4\u2009+\u2009CD25\u2009+\u2009T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific Immunomodulation. Cytotherapy. 2024;26:126\u201335.","journal-title":"Cytotherapy"},{"key":"3677_CR95","doi-asserted-by":"crossref","unstructured":"Bellinghausen I, Khatri R, Saloga J. Current strategies to modulate regulatory T cell activity in allergic inflammation. Front Immunol. 2022;13:912529.","DOI":"10.3389\/fimmu.2022.912529"},{"key":"3677_CR96","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41584-024-01139-z","volume":"20","author":"G Schett","year":"2024","unstructured":"Schett G, M\u00fcller F, Taubmann J, Mackensen A, Wang W, Furie RA, Gold R, Haghikia A, Merkel PA, Caricchio R, et al. Advancements and challenges in CAR T cell therapy in autoimmune diseases. Nat Rev Rheumatol. 2024;20:531\u201344.","journal-title":"Nat Rev Rheumatol"},{"key":"3677_CR97","doi-asserted-by":"crossref","unstructured":"Mukhatayev Z, Dellacecca ER, Cosgrove C, Shivde R, Jaishankar D, Pontarolo-Maag K, et al. Antigen specificity enhances disease control by Tregs in vitiligo. Front Immunol. 2020;11:581433.","DOI":"10.3389\/fimmu.2020.581433"},{"key":"3677_CR98","doi-asserted-by":"crossref","unstructured":"Cheng J, Hu X, Dai Z, Zeng Y, Jin J, Mu W, et al. Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells. JCI Insight. 2025;10:e178572.","DOI":"10.1172\/jci.insight.178572"},{"key":"3677_CR99","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12943-021-01472-x","volume":"21","author":"X Cui","year":"2022","unstructured":"Cui X, Zhang C, Xu Z, Wang S, Li X, Stringer-Reasor E, Bae S, Zeng L, Zhao D, Liu R, et al. Dual CRISPR interference and activation for targeted reactivation of X-linked endogenous FOXP3 in human breast cancer cells. Mol Cancer. 2022;21:38.","journal-title":"Mol Cancer"},{"key":"3677_CR100","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/imm.13690","volume":"170","author":"I Cosorich","year":"2023","unstructured":"Cosorich I, Filoni J, Di Dedda C, Ferrari A, Jofra T, Cesarano S, Bonini C, Piemonti L, Monti P. Interleukin-7 improves the fitness of regulatory T cells for adoptive transfer. Immunology. 2023;170:540\u201352.","journal-title":"Immunology"},{"key":"3677_CR101","doi-asserted-by":"crossref","unstructured":"Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10:e005151.","DOI":"10.1136\/jitc-2022-005151"},{"key":"3677_CR102","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41419-024-07086-7","volume":"15","author":"L Zhu","year":"2024","unstructured":"Zhu L, Liu Z, Cui Q, Guan G, Hui R, Wang X, Wang J, Zhang Y, Zhu X. Epigenetic modification of CD4(+) T cells into Tregs by 5-azacytidine as cellular therapeutic for atherosclerosis treatment. Cell Death Dis. 2024;15:689.","journal-title":"Cell Death Dis"},{"key":"3677_CR103","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/biomedicines12051022","volume":"12","author":"DD Zhdanov","year":"2024","unstructured":"Zhdanov DD, Gladilina YA, Blinova VG, Abramova AA, Shishparenok AN, Eliseeva DD. Induction of FoxP3 Pre-mRNA alternative splicing to enhance the suppressive activity of regulatory T cells from amyotrophic lateral sclerosis patients. Biomedicines. 2024;12:1022.","journal-title":"Biomedicines"},{"key":"3677_CR104","doi-asserted-by":"crossref","unstructured":"Galea R, Nel HJ, Talekar M, Liu X, Ooi JD, Huynh M, et al. PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease. JCI Insight. 2019;4:e126025.","DOI":"10.1172\/jci.insight.126025"},{"key":"3677_CR105","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.tibtech.2024.11.017","volume":"43","author":"W Gong","year":"2025","unstructured":"Gong W, Liu Z, Wang Y, Huang W, Yang K, Gao Z, Guo K, Xiao Z, Zhao W. Reprogramming of Treg cell-derived small extracellular vesicles effectively prevents intestinal inflammation from PANoptosis by blocking mitochondrial oxidative stress. Trends Biotechnol. 2025;43:893\u2013917.","journal-title":"Trends Biotechnol"},{"key":"3677_CR106","doi-asserted-by":"publisher","first-page":"e2312088","DOI":"10.1002\/adma.202312088","volume":"36","author":"N Younis","year":"2024","unstructured":"Younis N, Puigmal N, Kurdi AE, Badaoui A, Zhang D, Morales-Garay C, Saad A, Cruz D, Rahy NA, Daccache A, et al. Microneedle-Mediated delivery of immunomodulators restores immune privilege in hair follicles and reverses immune-Mediated alopecia. Adv Mater. 2024;36:e2312088.","journal-title":"Adv Mater"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03677-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03677-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03677-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:03:00Z","timestamp":1770210180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-025-03677-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3677"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03677-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}